STAGE III NSCLC
Clinical trials for STAGE III NSCLC explained in plain language.
Never miss a new study
Get alerted when new STAGE III NSCLC trials appear
Sign up with your email to follow new studies for STAGE III NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo before lung cancer surgery shows promise in early trial
Disease control Recruiting nowThis study tests whether giving a combination of immunotherapy (tislelizumab) and chemotherapy before surgery can help more people with stage III PD-L1 positive non-small cell lung cancer have a complete removal of their tumor. About 30 adults who are current or former smokers an…
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated May 26, 2026 10:49 UTC
-
New combo therapy aims to extend life for Hard-to-Treat lung cancer patients
Disease control Recruiting nowThis study tests whether giving immunotherapy with chemotherapy before radiation can help elderly or less fit patients with stage III lung cancer live longer without their cancer getting worse. About 152 participants will receive either the new combination or standard care. The g…
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated May 26, 2026 10:42 UTC